BOLERO-2研究解读: 依维莫司联合依西美坦在激素受体阳性进展性乳腺癌的临床实践依据

    The Interpretation of BOLERO-2 Trial: Clinical Application Analysis on Everolimus Plus Exemestane for Hormone Receptor-Positive Advanced Breast Cancer

    /

    返回文章
    返回